FORALLVENT

Related studies

A number of ongoing initiatives funded by the European Commission are currently conducting research into asthma and allergies among children, adolescents and adults. Amongst them are the ISAAC Phase II-, PARSIFAL-, PASTURE-, GABRIEL- and EUROPREVALL-Study as well as the GA2LEN Network of Excellence. Members of the FORALLVENT group are active in these studies.

Pasture

The PASTURE birth cohort study follows enrolled newborn children from farm and non-farm families up to the age of one year (winter 2001-spring 2006).

The study investigates environments which previous studies have shown to be highly protective against the development of allergies. The aim is to identify the preconditions for developing tolerance towards environmental allergens early in life. As the children remain in the study up to an age in which asthma and atopy can be ascertained with reasonable certainty, it offers a unique opportunity to detect factors and/or substances which protect against asthma and allergies. PASTURE website in German

EFRAIM

EFRAIM - Mechanisms of Early Protective Exposures on Allergy Development (continuation of the PASTURE cohort)

 

 

GA2LEN

The Global Allergy and Asthma European Network (GA2LEN) aims to enhance the quality and relevance of all aspects of allergy research in Europe. Read more in
RTDinfo, Magazine on European Research No.41

GABRIEL

The GABRIEL Study addresses the genetic and genomic component of the complex, multi-facetted disease pattern of allergic illnesses.

EUROPREVALL

The goal of the EUROPREVALL Study is to identify key risk factors for the development of food allergies. It will examine the complex interactions between food intake and metabolism, immune system, genetic background and socioeconomic factors 

DIABIMMUNE

DIABIMMUNE - Pathogenesis of Type 1 Diabetes: Testing the Hygiene Hypothesis

SOLAR II

SOLAR II - Study on Occupational Allergy Risks II

GALTRAIN

The GALTRAIN Network has been established as a Marie Curie consortium of 6 institutions in the United Kingdom, Germany and the Netherlands. The aim of the network is to provide early stage research training in the causes for the rise in asthma and allergic diseases in the developed world.

One in four European children under the age of 10 suffers from an allergy. Why is this a growing problem? Are the causes environmental or hereditary? Why is it that, despite relatively homogenous lifestyles in apparently comparable countries, the percentages of allergy sufferers show such marked contrasts? All in all, the scientists have certainly not finished grappling with the allergy headache. As part of their efforts, 25 leading research teams have come together within the GA2LEN European network of excellence.


Read RTDinfo, Magazine on European Research No.41